Deploying Randomized Controlled Trials during the COVID-19 Pandemic: Reason and Bayesian Designs
Open Access
- 1 August 2020
- journal article
- editorial
- Published by American Thoracic Society in Annals of the American Thoracic Society
- Vol. 17 (8), 937-938
- https://doi.org/10.1513/annalsats.202005-463ed
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator TrialAnnals of the American Thoracic Society, 2020
- The Urgency of Care during the Covid-19 Pandemic — Learning as We GoThe New England Journal of Medicine, 2020
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19The New England Journal of Medicine, 2020
- Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK TrialAmerican Journal of Respiratory and Critical Care Medicine, 2020
- Macrolides in critically ill patients with Middle East Respiratory SyndromeInternational Journal of Infectious Diseases, 2019
- Network meta-analysis: a technique to gather evidence from direct and indirect comparisonsPharmacy Practice (Internet), 2017